13 Einträge gefunden

1. Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma.

   1. Ayuketang Ayuk, Francis
   2. Shimoni, A
   3. Nagler, A
   4. Schwerdtfeger, R
   5. Kiehl, M
   6. Sayer, H G
   7. Zabelina, Tatjana

   2004 - Forschungsinformationssystem des UKE
2. Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis.

   1. Schetelig, J
   2. Bornhäuser, M
   3. Kiehl, M
   4. Schwerdtfeger, R
   5. Kröger, N
   6. Runde, V
   7. Zabelina, Tatjana

   2004 - Forschungsinformationssystem des UKE
3. ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML).

   1. Zander, A R
   2. Kröger, N
   3. Schleuning, M
   4. Finke, J
   5. Zabelina, Tatjana
   6. Beelen, D
   7. Schwerdtfeger, R

   2003 - Forschungsinformationssystem des UKE
4. Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation.

   1. Weber, M
   2. Kröger, N
   3. Langer, F
   4. Hansen, A
   5. Zabelina, Tatjana
   6. Eifrig, B
   7. Hossfeld, D K

   2003 - Forschungsinformationssystem des UKE
5. [Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG]

   1. Graf Finckenstein, F
   2. Zabelina, Tatjana
   3. Dürken, M
   4. Dahlke, J
   5. Kröger, N
   6. Krüger, W
   7. Janka-Schaub, Gritta

   2002 - Forschungsinformationssystem des UKE
6. In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors.

   1. Kröger, N
   2. Zabelina, Tatjana
   3. Krüger, W
   4. Renges, H
   5. Stute, N
   6. Rischewski, J
   7. Sonnenberg, S

   2002 - Forschungsinformationssystem des UKE
7. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.

   1. Kröger, N
   2. Zabelina, Tatjana
   3. Renges, H
   4. Krüger, W
   5. Kordes, Uwe
   6. Rischewski, J
   7. Schrum, Johanna

   2002 - Forschungsinformationssystem des UKE
8. Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma.

   1. Kröger, N
   2. Krüger, W
   3. Renges, H
   4. Zabelina, Tatjana
   5. Stute, N
   6. Jung, Roman
   7. Wittkowsky, G

   2001 - Forschungsinformationssystem des UKE
9. Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation.

   1. Fehse, B
   2. Chukhlovin, A
   3. Kühlcke, K
   4. Marinetz, O
   5. Vorwig, O
   6. Renges, H
   7. Krüger, W

   2001 - Forschungsinformationssystem des UKE
10. Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GvHD) in allogeneic stem cell transplantation from unrelated donors.

    1. Kröger, N
    2. Zabelina, Tatjana
    3. Krüger, W
    4. Renges, H
    5. Stute, N
    6. Dürken, M
    7. Graf von Finkenstein, F

    2001 - Forschungsinformationssystem des UKE
11. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.

    1. Kröger, N
    2. Schetelig, J
    3. Zabelina, Tatjana
    4. Krüger, W
    5. Renges, H
    6. Stute, N
    7. Schrum, Johanna

    2001 - Forschungsinformationssystem des UKE
12. Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients.

    1. Kröger, N
    2. Zabelina, Tatjana
    3. Krüger, W
    4. Renges, H
    5. Stute, N
    6. Kabisch, H
    7. Jaburg, N

    2001 - Forschungsinformationssystem des UKE
13. Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin.

    1. Kröger, N
    2. Zabelina, Tatjana
    3. Krüger, W
    4. Renges, H
    5. Stute, N
    6. Schrum, Johanna
    7. Kabisch, H

    2001 - Forschungsinformationssystem des UKE